
Sign up to save your podcasts
Or


Visit morningcommutepodcast.com/endometrial1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts on endometrial cancer discuss immune checkpoint inhibitors, including therapeutic rationale and their safety and efficacy as single agents and in combination therapies.
By @Point of Care5
1616 ratings
Visit morningcommutepodcast.com/endometrial1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts on endometrial cancer discuss immune checkpoint inhibitors, including therapeutic rationale and their safety and efficacy as single agents and in combination therapies.